Open AccessAS739, AT693 and AU734 antibodies label the spike S protein from SARS-CoV-2 by immunofluorescence
Author(s) -
Cyril Guilhen,
Nylsa Chammartin,
Célia Lazzarotto,
Sara Da Fonte,
Anthony Nemeth,
Clément Bindschaedler,
Zacharie El Matribi,
Serkan Berkcan,
Ezia Oppliger,
Daniel Bello Gil,
Clément Poncet,
Maxime Volery,
Ezgi Gozlugol,
Margaux Gosetto,
Nina Payot,
Khatiba Khatibi,
Emma Jaques,
Manfred Schmid,
Julien Ollivier,
Alexandre P. Vaudano,
François Prodon,
Ali Sassi
Publication year - 2021
Publication title -
antibody reports
Language(s) - English
Resource type - Journals
ISSN - 2624-8557
DOI - 10.24450/journals/abrep.2021.e305
Subject(s) - immunofluorescence , antibody , spike protein , recombinant dna , virology , covid-19 , spike (software development) , indirect immunofluorescence , biology , microbiology and biotechnology , medicine , immunology , pathology , biochemistry , computer science , gene , disease , software engineering , infectious disease (medical specialty)
The recombinant antibodies AS739, AT693 and AU734 detect by immunofluorescence the spike S protein from SARS-CoV-2.